Skip to content

PharmaBXL

Active
Private limited company·Overige zakelijke dienstverlening, neg· 3 yrs active
Zavelput 17 ·1000 Brussel, Belgium
KBO/BCE: BE 0795.508.480
Watch Print / PDF
Age3 yrs
Board2
Connections3
Real estate1 parcel · 212 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of PharmaBXL is 1.7% (moderate). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 12 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
How we compute the deadline
The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 30-09-2025 61 d late 2025-00526921
31-12-2023 31-07-2024 26-08-2024 26 d late 2024-00372308

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
1.7% Moderate
0%0,5%1,5%4%10%≥25%
Young company +Higher-failure-rate region +Lower-failure-rate sector −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
Financials being processed
NBB has 2 filing(s) on record for this company, latest fiscal year 2024 (micro). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 micro 30-09-2025 2025-00526921
31-12-2023 verkort 26-08-2024 2024-00372308

Directors

Directors & mandates

3 directors
Current directors & mandates
  • PharmaLegalLegal entity
    Managing director· perm. rep.: Georges DE FEU
    State Gazette act 26044294 (31-03-2026)
    Current
    13-02-2026 → present
  • REMEDIALegal entity
    Director· perm. rep.: Jo Ravelingien
    State Gazette act 23036160 (14-03-2023)
    Current
    06-02-2023 → present
Former directors (1)
  • O2CLegal entity
    Managing director· perm. rep.: Olivier OLBRECHTS
    State Gazette act 26044294 (31-03-2026)
    Former
    - → 13-02-2026
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Overige zakelijke dienstverlening, neg(82990)
Legal form Private limited company(610)
Incorporation29-12-2022
StatusActive
Postal code1000

Structure & network

Connections & network

3 connected companies
PharmaLegal, Sits on the board PPharmaLegalREMEDIA, Sits on the board RREMEDIAREMEDUS, Shared corporate director RREMEDUSPharmaBXL PharmaBXL0795.508.480
Group structureShared directors
Group structure
PharmaLegal
Sits on the board · 1 subsidiary · 1 location
Control→
REMEDIA
Sits on the board · 2 subsidiaries · 1 location
Control→
Network connections
REMEDUS
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Ownership & control

2 parties
Control over this companysits on this company's board2
REMEDIA
2 subsidiaries · 1 location
PharmaLegal
1 subsidiary · 1 location
controls
PharmaBXLBE 0795.508.480

Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Zavelput 171000 Brussel

Establishment units

1 location
PharmaBXL
Zavelput 17, 1000 BrusselVervaardiging van farmaceutische grondstoffen
since 20222.340.231.797
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area212 m²
Buildings1
Building footprint172 m²
Volume (LiDAR)3,044 m³
Tallest building22.4 m · ±6 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21803C0405/00H000 Brussels 211 m² 1 · 172 m² 22.4 m · 6 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

7 acts
All acts · 7 updated 4 months ago
2026
13-04-2026 Act object · General meeting · Permanent representative · Officer resignation Open-capture extraction
  • Filing: 2026-04-03 · PharmaPROP.BXL
  • Publication: 2026-04-13 · PharmaPROP.BXL
  • Act object: Constatation changement représentant permanent · PharmaPROP.BXL
  • General meeting: 2026-02-13 · PharmaPROP.BXL
  • Permanent representative: role: représentant permanent, context: représentation de la société-administrateur PharmaBXL au sein de PharmaPROP.BXL, start_date: 2025-12-12 · Georges DE FEU
  • Officer resignation: role: représentant permanent, context: remplacement par Georges DE FEU, end_date: 2025-12-12 · Olivier OLBRECHTS
  • Approval: meeting_date: 2026-02-13, decision_date: 2025-12-12, approving_body: organe d'administration de la SRL PharmaBXL, approved_by_meeting: assemblée générale spéciale de PharmaPROP.BXL · PharmaPROP.BXL
Summary: Act object · General meeting · Permanent representative · Officer resignation
13-04-2026 Act object · General meeting · Officer resignation · Officer discharge Open-capture extraction
  • Filing: 2026-04-03 · PharmaOPS.BXL
  • Publication: 2026-04-13 · PharmaOPS.BXL
  • Act object: Démission administrateur - Constatation changement représentant permanent · PharmaOPS.BXL
  • General meeting: 2026-02-13 · PharmaOPS.BXL
  • Officer resignation: role: administrateur, effective_date: 2025-12-12 · Georges DE FEU
  • Officer discharge · Georges DE FEU
  • Permanent representative: role: représentant permanent, for_company: PharmaOPS.BXL, effective_date: 2025-12-12 · Georges DE FEU
  • Permanent representative: role: représentant permanent, status: ceased, for_company: PharmaOPS.BXL, effective_date: 2025-12-12 · Olivier OLBRECHTS
Summary: Act object · General meeting · Officer resignation · Officer discharge
31-03-2026 Act object · Board meeting · Officer resignation · Officer appointment Open-capture extraction
  • Filing: 2026-03-24 · PharmaBXL
  • Act object: Ontslag en benoeming gedelegeerd bestuurder · PharmaBXL
  • Board meeting: 2026-02-13 · PharmaBXL
  • Officer resignation: role: gedelegeerd bestuurder, effective_date: 2026-02-13 · O2C
  • Officer appointment: role: gedelegeerd bestuurder, duration: onbepaalde duur, effective_date: 2026-02-13 · PharmaLegal
  • Publication: 2026-03-31
Summary: Act object · Board meeting · Officer resignation · Officer appointment
26-01-2026 Articles of association amended, translation of the articles, coordination of the articles and amendment of specific articles Statutes amendment·Tim CARNEWAL
Notary: Tim CARNEWAL · BrusselFirm: BERQUIN NOTARISSEN
2023
14-03-2023 Jo Ravelingien appointed as director Director changes
  • Jo Ravelingien, Bestuurder
Summary: v3.2
01-02-2023 Articles of association amended Statutes amendment
Summary: v3.2
02-01-2023 Incorporation of a new BV Incorporation
Summary: oprichting

Analysis

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector and region
We hold no filed accounts for this company, so a size comparison is not possible. These companies share only the sector and the region. We hold annual accounts for 2,967 of the 24,463 companies in this sector.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Apotheken47730Detailhandel in farmaceutische producten47730Overige zakelijke dienstverlening, neg82990Groothandel in parfumerieën en cosmetica46450Groothandel in parfumerieën en cosmetica46450Holdings64200Activiteiten van holdings64210
Primary activity highlighted.
Names & trade names
Legal nameNL PharmaBXL
Registered office
Zavelput 17
1000 Brussel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.